Logo 1 Logo 2

Clinical Trial Details

Trial ID: L0779
Source ID: NCT00399256
Associated Drug: Acetylcysteine
Title: Improved Estimation of GFR by Cystatin C in Preventing Contrast Induced Nephropathy by NAC or Zn
Acronym:
Status: TERMINATED
Study Results: NO
Results:
Conditions: Chronic Kidney Failure
Interventions: DRUG: Acetylcysteine|DRUG: Zinc
Outcome Measures: Primary: Incidence of acute renal failure | Secondary: Rise in creatinine of > 0.5 mg/dl|Rise in creatinine > 25%|Significant rise in serum cystatin C)
Sponsor/Collaborators: Sponsor: Robert Bosch Gesellschaft für Medizinische Forschung mbH
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases:
Enrollment: 60
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: PREVENTION
Start Date: 2004-03
Completion Date: 2006-03
Results First Posted:
Last Update Posted: 2007-02-01
Locations: Robert-Bosch-Hospital, Stuttgart, D-70376, Germany
URL: https://clinicaltrials.gov/show/NCT00399256